Prednisone Plus Chloroquine for the Treatment of Hyper-reactive Malarial Splenomegaly

Summary

This randomized clinical trial will address a complication related to recurrent episodes of malaria in endemic areas - hyper-reactive malarial splenomegaly. We aim to assess the efficacy of chloroquine after prednisone-induction therapy compared to standard treatment of chloroquine alone in the treatment of adult patients with newly diagnosed hyper-reactive malarial splenomegaly.

Timeline

Start

2016-01

Primary completion

2017-02

Completion

2017-02

Drugs

Indications